130 related articles for article (PubMed ID: 9059850)
1. Cytokines and nitric oxide synthase inhibitor as mediators of adrenergic refractoriness in cardiac myocytes.
Oddis CV; Finkel MS
Eur J Pharmacol; 1997 Feb; 320(2-3):167-74. PubMed ID: 9059850
[TBL] [Abstract][Full Text] [Related]
2. Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes.
Oddis CV; Simmons RL; Hattler BG; Finkel MS
Biochem Biophys Res Commun; 1994 Dec; 205(2):992-7. PubMed ID: 7528506
[TBL] [Abstract][Full Text] [Related]
3. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes.
Kanai AJ; Mesaros S; Finkel MS; Oddis CV; Birder LA; Malinski T
Am J Physiol; 1997 Oct; 273(4):C1371-7. PubMed ID: 9357783
[TBL] [Abstract][Full Text] [Related]
5. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes.
Kurosaki K; Ikeda U; Maeda Y; Shimada K
J Mol Cell Cardiol; 2000 Feb; 32(2):333-9. PubMed ID: 10722808
[TBL] [Abstract][Full Text] [Related]
7. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
Harding SE; Davies CH; Money-Kyrle AM; Poole-Wilson PA
Cardiovasc Res; 1998 Dec; 40(3):523-9. PubMed ID: 10070493
[TBL] [Abstract][Full Text] [Related]
8. beta-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1beta via message stabilization.
Gustafsson AB; Brunton LL
Mol Pharmacol; 2000 Dec; 58(6):1470-8. PubMed ID: 11093787
[TBL] [Abstract][Full Text] [Related]
9. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347
[TBL] [Abstract][Full Text] [Related]
10. Cytokines increase neonatal cardiac myocyte calcium concentrations: the involvement of nitric oxide and cyclic nucleotides.
Bick RJ; Wood DE; Poindexter B; McMillin JB; Karoly A; Wang D; Bunting R; McCann T; Law GJ; Buja LM
J Interferon Cytokine Res; 1999 Jun; 19(6):645-53. PubMed ID: 10433366
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
12. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes.
Kinugawa KI; Kohmoto O; Yao A; Serizawa T; Takahashi T
Am J Physiol; 1997 Jan; 272(1 Pt 2):H35-47. PubMed ID: 9038920
[TBL] [Abstract][Full Text] [Related]
13. β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.
Limberg JK; Johansson RE; Peltonen GL; Harrell JW; Kellawan JM; Eldridge MW; Sebranek JJ; Schrage WG
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H756-64. PubMed ID: 26747505
[TBL] [Abstract][Full Text] [Related]
14. Induction of nitric oxide synthase in human vascular smooth muscle: interactions between proinflammatory cytokines.
Chester AH; Borland JA; Buttery LD; Mitchell JA; Cunningham DA; Hafizi S; Hoare GS; Springall DR; Polak JM; Yacoub MH
Cardiovasc Res; 1998 Jun; 38(3):814-21. PubMed ID: 9747450
[TBL] [Abstract][Full Text] [Related]
15. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists.
Ungureanu-Longrois D; Balligand JL; Simmons WW; Okada I; Kobzik L; Lowenstein CJ; Kunkel SL; Michel T; Kelly RA; Smith TW
Circ Res; 1995 Sep; 77(3):494-502. PubMed ID: 7543826
[TBL] [Abstract][Full Text] [Related]
16. Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.
Yamamoto S; Tsutsui H; Tagawa H; Saito K; Takahashi M; Tada H; Yamamoto M; Katoh M; Egashira K; Takeshita A
Circulation; 1997 Mar; 95(5):1111-4. PubMed ID: 9054836
[TBL] [Abstract][Full Text] [Related]
17. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
[TBL] [Abstract][Full Text] [Related]
18. Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man.
Schmetterer L; Dallinger S; Polak K; Eichler HG; Wolzt M
Nitric Oxide; 1999 Jun; 3(3):209-15. PubMed ID: 10442852
[TBL] [Abstract][Full Text] [Related]
19. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
Gealekman O; Abassi Z; Rubinstein I; Winaver J; Binah O
Circulation; 2002 Jan; 105(2):236-43. PubMed ID: 11790707
[TBL] [Abstract][Full Text] [Related]
20. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.
Ashley EA; Sears CE; Bryant SM; Watkins HC; Casadei B
Circulation; 2002 Jun; 105(25):3011-6. PubMed ID: 12081996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
